ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,326, issued on Aug. 4, was assigned to Incyte Corp. (Wilmington, Del.).
"Anti-CD19 antibody formulations" was invented by Patrick Garidel (Ingelheim am Rhein, Germany), Andreas Langer (Ingelheim am Rhein, Germany), Martin Hessling (Biberach an der RiB, Germany), Daniel Weinfurtner (Planegg, Germany) and Bodo Brocks (Planegg, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure describes a pharmaceutical formulation of an anti-CD19 antibody."
The patent was filed on March 22, 2022, under Application No. 17/700,809.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph...